4% Chlorhexidine Gluconate Daily Bathing for Prevention of Hospital-acquired Infections in Intensive Care Settings

NCT ID: NCT03639363

Last Updated: 2018-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

449 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-10

Study Completion Date

2016-05-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will assess the utility of 4% chlorhexidine gluconate (CHG) daily bathing to reduce hospital acquired infections in patients admitted to intensive care units. One group will be daily bathed with 4% CHG and the other group with standard soap.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospital Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Arm

daily bathing with 4% chlorhexidine gluconate soap-like solution followed by water rinsing

Group Type EXPERIMENTAL

4% chlorhexidine gluconate soap-like solution

Intervention Type DRUG

1. humidify the whole body surface with the exception of the face using water-impregnated washcloths
2. use 4% CHG-impregnated washcloths to bath the whole body surface with the exception of the face; use at least 30 ml of 4% CHG
3. wait for at least 30 seconds
4. rinse using water-impregnated washcloths

Control Arm

daily bathing with standard soap

Group Type ACTIVE_COMPARATOR

standard soap

Intervention Type OTHER

1. humidify the whole body surface with the exception of the face using water-impregnated washcloths
2. use standard soap-impregnated washcloths to bath the whole body surface with the exception of the face
3. wait for at least 30 seconds
4. rinse using water-impregnated washcloths

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

4% chlorhexidine gluconate soap-like solution

1. humidify the whole body surface with the exception of the face using water-impregnated washcloths
2. use 4% CHG-impregnated washcloths to bath the whole body surface with the exception of the face; use at least 30 ml of 4% CHG
3. wait for at least 30 seconds
4. rinse using water-impregnated washcloths

Intervention Type DRUG

standard soap

1. humidify the whole body surface with the exception of the face using water-impregnated washcloths
2. use standard soap-impregnated washcloths to bath the whole body surface with the exception of the face
3. wait for at least 30 seconds
4. rinse using water-impregnated washcloths

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* admission to the intensive care unit (ICU) or to the post-operative cardiosurgical ICU (PC-ICU)
* ICU/PC-ICU stay for at least 1 night

Exclusion Criteria

* known allergy to chlorhexidine
* burns, toxic epidermal necrolysis or Stevens-Johnson syndrome as admission diagnosis
* pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Toscana Gabriele Monasterio

OTHER

Sponsor Role collaborator

University Of Perugia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carlo Pallotto

Medical Doctor, Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

franco baldelli, Professor

Role: STUDY_CHAIR

Infectious Diseases Clinical, University Hospital of Perugia, Perugia, Italy

References

Explore related publications, articles, or registry entries linked to this study.

Pallotto C, Fiorio M, De Angelis V, Ripoli A, Franciosini E, Quondam Girolamo L, Volpi F, Iorio P, Francisci D, Tascini C, Baldelli F. Daily bathing with 4% chlorhexidine gluconate in intensive care settings: a randomized controlled trial. Clin Microbiol Infect. 2019 Jun;25(6):705-710. doi: 10.1016/j.cmi.2018.09.012. Epub 2018 Sep 26.

Reference Type DERIVED
PMID: 30267930 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Duclorexint

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Chlorhexidine on Bacteriuria
NCT02032394 UNKNOWN PHASE4